Cas no 87573-88-4 (2(1H)-Pyrimidinone,5-acetyl-)
2(1H)-Pyrimidinone,5-acetyl- Chemical and Physical Properties
Names and Identifiers
-
- 2(1H)-Pyrimidinone,5-acetyl-
- 2(1H)-Pyrimidinone, 5-acetyl- (9CI)
- AKOS006356032
- 5-ACETYL-1H-PYRIMIDIN-2-ONE
- 1-(2-Hydroxypyrimidin-5-yl)ethanone
- F13147
- 87573-88-4
- MFCD29921801
- 1-(2-hydroxypyrimidin-5-yl)ethan-1-one
- 5-acetylpyrimidone
- SB56083
- SCHEMBL9768122
-
- MDL: MFCD29921801
- Inchi: 1S/C6H6N2O2/c1-4(9)5-2-7-6(10)8-3-5/h2-3H,1H3,(H,7,8,10)
- InChI Key: JVKOPTGVTQBZOX-UHFFFAOYSA-N
- SMILES: O=C(C)C1C=NC(NC=1)=O
Computed Properties
- Exact Mass: 138.042927438g/mol
- Monoisotopic Mass: 138.042927438g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 240
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.8
- Topological Polar Surface Area: 58.5?2
2(1H)-Pyrimidinone,5-acetyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB512535-250 mg |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 250MG |
€378.50 | 2023-04-18 | ||
| abcr | AB512535-1 g |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 1g |
€866.30 | 2023-04-18 | ||
| Chemenu | CM363265-1g |
1-(2-hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 95%+ | 1g |
$521 | 2023-02-01 | |
| abcr | AB512535-250mg |
1-(2-Hydroxypyrimidin-5-yl)ethanone; . |
87573-88-4 | 250mg |
€672.30 | 2025-04-15 | ||
| abcr | AB512535-1g |
1-(2-Hydroxypyrimidin-5-yl)ethanone; . |
87573-88-4 | 1g |
€1539.00 | 2025-04-15 | ||
| Ambeed | A860708-1g |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 97% | 1g |
$474.0 | 2024-04-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1744993-1g |
5-Acetylpyrimidin-2(1h)-one |
87573-88-4 | 98% | 1g |
¥3318.00 | 2024-04-27 | |
| Crysdot LLC | CD11038159-1g |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 97% | 1g |
$474 | 2024-07-18 | |
| 1PlusChem | 1P01X8E4-100mg |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 95% | 100mg |
$258.00 | 2024-04-20 | |
| 1PlusChem | 1P01X8E4-250mg |
1-(2-Hydroxypyrimidin-5-yl)ethanone |
87573-88-4 | 95% | 250mg |
$476.00 | 2024-04-20 |
2(1H)-Pyrimidinone,5-acetyl- Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
Additional information on 2(1H)-Pyrimidinone,5-acetyl-
Recent Advances in the Study of 2(1H)-Pyrimidinone,5-acetyl- (CAS: 87573-88-4): A Comprehensive Research Brief
The compound 2(1H)-Pyrimidinone,5-acetyl- (CAS: 87573-88-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This research brief aims to synthesize the latest findings regarding its synthesis, biological activity, and pharmacological relevance, providing a concise yet comprehensive overview for professionals in the field.
Recent studies have highlighted the role of 2(1H)-Pyrimidinone,5-acetyl- as a key intermediate in the synthesis of novel heterocyclic compounds with promising antimicrobial and anticancer properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a scaffold for developing inhibitors targeting bacterial DNA gyrase, showcasing its potential in addressing antibiotic resistance. The compound's unique structural features, including the acetyl group at the 5-position, contribute to its ability to interact with specific biological targets, making it a valuable candidate for further drug development.
In addition to its antimicrobial potential, 2(1H)-Pyrimidinone,5-acetyl- has been investigated for its role in modulating cellular signaling pathways. A recent preprint on bioRxiv revealed its inhibitory effects on certain kinases involved in inflammatory responses, suggesting its applicability in treating chronic inflammatory diseases. The study utilized molecular docking simulations and in vitro assays to validate these interactions, providing a robust foundation for future in vivo studies.
From a synthetic chemistry perspective, advancements in the efficient production of 2(1H)-Pyrimidinone,5-acetyl- have been reported. A 2024 paper in Organic Process Research & Development detailed a novel catalytic method that improves yield and reduces byproducts, addressing previous challenges in large-scale synthesis. This methodological innovation is expected to facilitate broader accessibility of the compound for both research and industrial applications.
Looking ahead, the versatility of 2(1H)-Pyrimidinone,5-acetyl- continues to inspire multidisciplinary research. Ongoing clinical trials are exploring its derivatives as potential therapeutics for neurodegenerative disorders, leveraging its ability to cross the blood-brain barrier. As the scientific community deepens its understanding of this compound's mechanisms of action, its impact on drug discovery pipelines is anticipated to grow significantly in the coming years.
87573-88-4 (2(1H)-Pyrimidinone,5-acetyl-) Related Products
- 1263094-76-3(5-acetyl-4-methyl-2(1H)-pyrimidinone hydrochloride)
- 64171-57-9(2(1H)-Pyrimidinone,5-propyl-)
- 64171-56-8(5-ethyl-2-pyrimidinol hydrochloride)
- 110100-03-3(2(1H)-Pyrimidinone, 5-(1-oxopentyl)-)
- 97941-18-9(2(1H)-Pyrimidinone, 5-hexyl-)
- 117889-72-2(5-ethyl-2-pyrimidinol hydrochloride)
- 108572-43-6(2(1H)-Pyrimidinone, 5-octyl-)
- 166757-62-6(2-Hydroxypyrimidine-5-carbaldehyde)
- 113246-41-6(5-Acetyl-4-methylpyrimidin-2(1H)-one)
- 64171-59-1(2(1H)-Pyrimidinone, 5-pentyl-)